Cynosure to Present at UBS Global Life Sciences Conference
Presentation to be Webcast Live at 3:00 p.m. ET Tuesday, September 21
WESTFORD, Mass., Sept. 16 -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that it will present at the UBS Global Life Sciences Conference in New York on Tuesday, September 21.
The presentation by President and Chief Executive Officer Michael Davin and Executive Vice President, Treasurer and Chief Financial Officer Timothy Baker is scheduled to begin at 3:00 p.m. ET on September 21. To access the live or archived webcast of the event, visit the "Investor Relations" section of Cynosure's website, www.cynosure.com.
About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit www.cynosure.com.
Source: Cynosure, Inc.
Contact:
Scott Solomon
Vice President
Sharon Merrill Associates, Inc.
617.542.5300
cyno@investorrelations.com
Web Site: www.cynosure.com/
